BBHvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with BBH, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 04/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBH ETF 2 | +1.88%– | -7.18%– | -1.86%– | +24.34%– | +15.09%– | -0.59%– |
| Flows | BBH ETF 2 | -$2M– | -$4M– | -$4M– | -$52M– | -$188M– | -$130M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBH ETF 2 | +20.75%– | +20.44%– | +18.72%– | +21.44%– |
| Max drawdown | BBH ETF 2 | -10.45%– | -10.45%– | -22.78%– | -39.88%– |
| Max drawdown duration | BBH ETF 2 | 87d– | 87d– | 440d– | 1719d– |
Trading data
BBH | ETF 2 | |
Last sale 4/27/2026 at 1:30 PM | $184.15 | – |
| Previous close 04/24/2026 | $185.67 | – |
| Consolidated volume 04/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of March 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BBH | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 4/27/2026 at 1:30 PM
Live
Closed
BBH | ETF 2 | |
|---|---|---|
| Last price | $184.15 | – |
| 1D performance | -0.82% | – |
| AuM | $365.13 M | – |
| E/R | 0.35% | – |
Characteristics
BBH | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | VanEck | – |
| Benchmark | MVIS US Listed Biotech 25 Index | – |
| N° of holdings | 21 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 20, 2011 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
BBH
USA
97.6%
Other
2.4%
ETF 2
Sectors
BBH
Health Care
89.52%
Other
10.48%
ETF 2
Diversification
BBH
Total weight of top 15 holdings out of 15
86.44%
ETF 2
–
Top 15 holdings
Data as of March 31, 2026
BBH
AMGEN-T
14.84%
GILEAD SCIENCES
14.71%
VERTEX PHARMACEUTICALS
8.23%
REGENERON PHARMACEUTICALS
7.49%
US04016X1019
5.23%
INSMED
4.42%
IQVIA HOLDINGS INC
4.30%
ALNYLAM PHARMACEUTICALS
4.04%
BIOGEN INC
3.92%
UTD THERAPEUT
3.89%
NATERA
3.82%
US07725L1026
3.20%
MODERNA INC
3.03%
REVOLUTION MEDICINES INC
2.81%
ILLUMINA
2.51%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
